$1.1M award expands follow-up to six years with focus on clinical endpoints
Biomarker promises a practical way to reduce misdiagnoses
Relapse rates were lower with oral or infusion therapy after initial injectable DMT
No notable difference in reactions with two-hour infusion in ENSEMBLE PLUS substudy
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Observational studies comparing disease-modifying therapies can help guide clinical decisions
A focus on biological processes should improve both research and management
Initial pilot study findings suggest a potential reduced need for cerebrospinal fluid testing
New review makes the case for earlier pediatric enrollment and other changes
Single-arm, open-label study offers proof of concept for MSC-NTF cells
Selective DHODH inhibitor designed as a better-tolerated alternative to teriflunomide